<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-X27J3MLA/915aad64-136a-4062-b31b-c1b715928c65/PDF"><dcterms:extent>2030 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-X27J3MLA/f2e28607-91b6-4894-ae90-dbec1c9e80ba/TEXT"><dcterms:extent>12 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-X27J3MLA"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:SPR-WQVGMCSC" /><dcterms:issued>1999</dcterms:issued><dc:creator>Kokelj, F...</dc:creator><dc:creator>Plozzer, C...</dc:creator><dc:creator>Trevisan, G...</dc:creator><dc:format xml:lang="sl">številka:3</dc:format><dc:format xml:lang="sl">letnik:8</dc:format><dc:format xml:lang="sl">str. 101-104</dc:format><dc:identifier>COBISSID_HOST:10701273</dc:identifier><dc:identifier>ISSN:1318-4458</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-X27J3MLA</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Slovene Welding Society</dc:publisher><dcterms:isPartOf xml:lang="sl">Acta dermatovenerologica Alpina, Pannonica et Adriatica</dcterms:isPartOf><dc:subject xml:lang="sl">Adverse effects</dc:subject><dc:subject xml:lang="sl">Cyclosporine</dc:subject><dc:subject xml:lang="sl">Drug therapy</dc:subject><dc:subject xml:lang="sl">Etretinate</dc:subject><dc:subject xml:lang="sl">Psoriasis</dc:subject><dc:subject xml:lang="sl">Retinoids</dc:subject><dc:subject xml:lang="sl">Vitamin d</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Adverse events due to psoriasis treatment|</dc:title><dc:description xml:lang="sl">Any treatment can cause some undesired reactions that may be local, systemic, predictable or unpredictable. In the present study we describe our experience concerning the incidence of drug reactions caused by the most common psoriatictreatments. Both topical, vitamin D derivatives and topical retinoids, or systemic, etretinate and cyclosporin A, can cause a large spectrum of adverse reactions that must be known and considered by both doctors and patients in order to obtain the best clinical results. In this paper we summarize our experience with the more common and recent treatments for psoriasis</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-X27J3MLA"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-X27J3MLA" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-X27J3MLA/915aad64-136a-4062-b31b-c1b715928c65/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Združenje slovenskih dermatovenerologov</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-X27J3MLA/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-X27J3MLA" /></ore:Aggregation></rdf:RDF>